Rivastigmine tartrate
Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
| Catalog Number | T1628 |
| Alternative Name(s) | SDZ-ENA 713 , ENA 713 |
| Research Area | Neuroscience |
| Molecular Formula | C14H22N2O2·C4H6O6 |
| CAS# | 129101-54-8 |
| Purity | 99.66% |
| SMILES | O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Rivastigmine tartrate |
| Additional Information | https://www.targetmol.com/datasheet/T1628 |
